Last reviewed · How we verify

NCT05474651

Influencing Factors and Trigger Mechanism of Relapse in Expectant Fathers Who Quit Smoking

Active, enrolled Last updated 2 May 2024
What this trial tests

trial testing Questionnaires set in Smoking Cessation in 294 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
23 November 2022
Primary endpoint
28 February 2024
30 April 2024

Quick facts

Lead sponsorSun Yat-sen University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment294
Start date23 November 2022
Primary completion28 February 2024
Estimated completion30 April 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Sun Yat-sen University

Who can join

18 and older, male only, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to describe the relapse rate and characteristics of expectant fathers who quit smoking during their wives' pregnancy, to explore the influencing factors and triggering mechanisms,and describe their experience.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaires set

Trials testing the same drug.

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other Sun Yat-sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05474651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing